Friday, March 17, 2017

Eyeking Renews Under Armour Eyewear Partnership with Caddy For A Cure in 2017

(Melville, NY) - Eyeking, the leading designer and manufacturer of Under Armour Eyewear, announced that following a successful first year, UA Eyewear and Caddy For A Cure will renew their partnership for 2017.

Caddy For A Cure is a nationally recognized program in professional golf that provides support and rehabilitation for combat-injured military veterans. Eyeking will provide UA Eyewear for all 2017 participants in order to enhance their on-course caddy experience with the best golfers in the world.

Eyeking is internationally recognized for superior eyewear design, manufacturing and distribution of a portfolio of eyewear brands and licenses. UA Eyewear is a leading sport performance brand with advanced lens technology, ultra-lightweight frame construction, and multiple layers of comfort. Eyeking’s dedication to innovative engineering and revolutionary materials has made UA Eyewear the brand of choice for professional golfers who rely on it for superior comfort, fit and protection.

“The UA Eyewear team is driven every day to perform on the cutting edge of product innovation. In 2016, we saw first-hand what Caddy For A Cure was doing in the world of golf and we knew that this was the perfect partnership for UA Eyewear to continue with,” says Scott Betty, SVP, Product, Design & Marketing for UA Eyewear. “Through the game of golf, we are honored to support our military heroes in conjunction with the Caddy For A Cure program.”

Russ Holden, the Caddy For A Cure program founder and CEO, commented on this renewed relationship with UA Eyewear and Eyeking, "We are incredibly excited to have this sponsorship support from UA Eyewear. They are perhaps the most exciting and innovative eyewear brand today, but more importantly, they are a company with values that parallel ours in supporting our military veterans.”

For more information on Eyeking, visit www.eyeking.com.

For more information visit www.caddyforacure.com.

No comments: